Cardiothoracic & vascular anesthesia

Chlorhexidine-alcohol compared with povidone-iodine-alcohol skin antisepsis protocols in major cardiac surgery: a randomized clinical trial

Intensive Care MedPublished Randomised controlled trial

Primary result · Reoperation within 90 daysResult — go to the resultRisk difference 0.25 95% CI - 1.58-2.07

Authors' conclusion

Among patients requiring sternotomy for major heart or aortic surgery, skin disinfection at the surgical site using chlorhexidine-alcohol was not superior to povidone-iodine-alcohol for reducing reoperation and surgical site infection rates.

Study context

Population
Adults undergoing major heart or aortic surgery via sternotomy, with or without saphenous vein or radial artery harvesting, 8 French hospitals
Participants
3,242 adults
Comparison
Chlorhexidine-alcohol vs Povidone-iodine-alcohol
  • Chlorhexidine-alcoholn = 1,621
  • Povidone-iodine-alcoholn = 1,621reference
Primary endpoint
Any resternotomy by day 90 or any reoperation at the peripheral surgical site by day 30
Methodological detailsmulticentre, open-label, two-arm, assessor-blind, superiority
  • Multicentre
  • Open-label
  • Two-arm
  • Assessor-blind
  • Superiority

Primary result

Reoperation within 90 days

Risk difference

0.25

95% CI - 1.58-2.07

P = 0.79

Events by treatment group

As reported in the abstract

Further findings

OutcomeChlorhexidine-alcoholPovidone-iodine-alcoholRisk difference (95% CI)P value
Surgical site infections at the sternum or peripheral sites4%3.3%0.74 (- 0.55-2.03)P = 0.26

Hospital LOS, ICU or hospital readmission, mortality

Similar between the two groups

Safety

Surgical site adverse events

Similar between the two groups

Original publication

Chlorhexidine-alcohol compared with povidone-iodine-alcohol skin antisepsis protocols in major cardiac surgery: a randomized clinical trial. Intensive Care Med. Published 12 November 2024. doi:10.1007/s00134-024-07693-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.